Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.75 |
| ▸ | CES1 | P23141 | 4/20 | 0.75 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.68 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.64 |
| ▸ | PPARG | P37231 | 7/20 | 0.64 |
| ▸ | PPARD | Q03181 | 7/20 | 0.64 |
| ▸ | PPARA | Q07869 | 7/20 | 0.64 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.64 |
| ▸ | TSHR | P16473 | 4/20 | 0.64 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | TLR2 | O60603 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | FABP4 | P15090 | 2/20 | 0.64 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.64 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | ESR1 | P03372 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL233056 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL10961549 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL8741844 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL17315852 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL3016254 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL284705 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL337998 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL337341 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL6817517 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG | |
| SCHEMBL648617 | 1.00 | CES2 (0.75) | CES2CES1HAO1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115594571-A | Preparation method of single-chain alkyl keto acid vesicle | 河南中医药大学（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-110791352-B | Oil-soluble graphene compound and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-05-10 | — | — | CN | claimed |
| CN-110791352-A | Novel oil-soluble graphene compound and preparation method and application thereof | 中国石油化工股份有限公司 | 2020-02-14 | — | — | CN | claimed |
| CN-107429272-A | For producing the method and material of 7 carbon compounds by C9 approach | 英威达纺织（英国）有限公司 | 2017-12-01 | — | — | CN | claimed |
| CN-107261148-A | Methylphenidate prodrug, its preparation and application | 凯姆制药公司 | 2017-10-20 | — | — | CN | claimed |
| EP-3224366-A1 | METHODS AND MATERIALS FOR PRODUCING 7-CARBON CHEMICALS VIA A C9 ROUTE | INVISTA TECHNOLOGIES S.A.R.L. (CH) | 2017-10-04 | — | — | EP | claimed |
| WO-2016085811-A1 | METHODS AND MATERIALS FOR PRODUCING 7-CARBON CHEMICALS VIA A C9 ROUTE | Invista North America S.á.r.l. (US) | 2016-06-02 | — | — | WO | claimed |
| US-20160145657-A1 | Methods and Materials for Producing 7-Carbon Chemicals via a C9 Route | INVISTA NORTH AMERICA S.A.R.L. | 2016-05-26 | — | — | US | claimed |
| CN-103826633-A | Methylphenidate prodrugs, methods of making and using the same | KEMPHARM INC | 2014-05-28 | — | — | CN | claimed |
| EP-0206741-B1 | LEUKOTRIENE ANTAGONISTS | MERCK FROSST CANADA INC. (CA) | 1991-04-10 | — | — | EP | claimed |
| US-12560617-B2 | Method of diagnosing and treatment monitoring of crohn's disease and ulcerative colitis | MCMASTER UNIVERSITY (CA) | 2026-02-24 | — | — | US | disclosed |
| WO-2025215576-A1 | A BAIT COMPOSITION | UPL LIMITED (IN) | 2025-10-16 | — | — | WO | disclosed |
| US-20240400637-A1 | COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS | PROTOMER TECHNOLOGIES INC. | 2024-12-05 | — | — | US | disclosed |
| CN-113195494-B | Synergistic compositions comprising non-racemic proportions of R-2- (substituted sulfonyl) -hexahydro-pyrrolo [1,2-a ] pyrazin-6 (2H) -one and S-2- (substituted sulfonyl) -hexahydro-pyrrolo [1,2-a ] pyrazin-6 (2H) -one | 美蒂斯制药公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-113376962-B | Coloring composition and compound | 住友化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| EP-0322861-A2 | Silver halide photographic material | Fuji Photo Film Co., Ltd. (JP) | 1989-07-05 | — | — | EP | disclosed |
| EP-0306999-A1 | Silver halide color photographic material | FUJI PHOTO FILM CO., LTD. (JP) | 1989-03-15 | — | — | EP | disclosed |
| US-4677029-A | Vapor-phase cure of coating compositions containing an aliphatic polyisocyanate and a tertiary amine polyahl | AKZO AMERICA INC. (US) | 1987-06-30 | — | — | US | disclosed |
| EP-0048159-A2 | Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents | UNIVERSITY OF MIAMI (US) | 1982-03-24 | — | — | EP | disclosed |
| US-4124608-A | Preparation of 2-oxoalkanoic acids | TEXACO INC. (US) | 1978-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400637-A1 | COMPOUNDS CONTAINING ONE OR MORE DIBORONATES AND RELATED INSULIN ANALOGS | GPR119, INSR, IAPP | CES2 162/4885CES1 105/4885HAO1 3722/4885 |
| US-12560617-B2 | Method of diagnosing and treatment monitoring of crohn's disease and ulcerative colitis | AADAT, GNMT, HNMT | CES2 4625/4885CES1 2876/4885HAO1 801/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.